Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-02-08 @ 2:23 PM
Study NCT ID:
NCT04052659
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-03-09
First Post:
2019-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab (IBI308) in Combination With Chidamide and Azacitidine in Refractory or Relapsed PTCL
Sponsor:
Peking University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Peripheral T-cell Lymphoma | View |
Keywords: